Deepak Kaushal

Antigen-specific B cells direct T follicular-like helper cells into lymphoid follicles to mediate Mycobacterium tuberculosis control

Data from Long-term <i>In vitro</i> Expansion Alters the Biology of Adult Mesenchymal Stem Cells

Data from Long-term <i>In vitro</i> Expansion Alters the Biology of Adult Mesenchymal Stem Cells

Supplementary Figure 2A from Long-term <i>In vitro</i> Expansion Alters the Biology of Adult Mesenchymal Stem Cells

The immunoregulatory landscape of human tuberculosis granulomas

Diagnosis of paediatric tuberculosis by optically detecting two virulence factors on extracellular vesicles in blood samples

Human M1 macrophages express unique innate immune response genes after mycobacterial infection to defend against tuberculosis

Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panel

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

A non-canonical type 2 immune response coordinates tuberculous granuloma formation and epithelialization

Visualizing the dynamics of tuberculosis pathology using molecular imaging

Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates

Lung Epithelial Signaling Mediates Early Vaccine-Induced CD4 ⁺ T Cell Activation and <i>Mycobacterium tuberculosis</i> Control

Pulmonary Mycobacterium tuberculosis control associates with CXCR3- and CCR6-expressing antigen-specific Th1 and Th17 cell recruitment

Chronic Immune Activation in TB/HIV Co-infection

Antiretroviral therapy does not reduce tuberculosis reactivation in a tuberculosis-HIV coinfection model

Formation of Lung Inducible Bronchus Associated Lymphoid Tissue Is Regulated by Mycobacterium tuberculosis Expressed Determinants

Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis

Mechanisms of reactivation of latent tuberculosis infection due to SIV coinfection

IMPACT-TB*: A Phase II Trial Assessing the Capacity of Low Dose Imatinib to Induce Myelopoiesis and Enhance Host Anti-Microbial Immunity Against Tuberculosis. *Imatinib Mesylate per Oral As a Clinical Therapeutic for TB

In vivo inhibition of tryptophan catabolism reorganizes the tuberculoma and augments immune-mediated control of<i>Mycobacterium tuberculosis</i>

CD4 ⁺ T-cell–independent mechanisms suppress reactivation of latent tuberculosis in a macaque model of HIV coinfection

S100A8/A9 Proteins Mediate Neutrophilic Inflammation and Lung Pathology during Tuberculosis